BNTC (STOCKS)
Benitec Biopharma Inc. Common Stock
$11.330000
+0.150000 (+1.34%)
Prev close: $11.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jerel A. Banks
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $389.92M
- Employees
- 19
- P/E (TTM)
- -12.03
- P/B (TTM)
- 2.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.05M |
| Operating Expenses | $46.60M |
| Research and Development | $18.37M |
| Other Operating Expenses | $28.23M |
| Operating Income/Loss | -$46.60M |
| Income/Loss From Continuing Operations After Tax | -$41.54M |
| Income/Loss From Continuing Operations Before Tax | -$41.54M |
| Net Income/Loss | -$41.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 86,759,812 |
| Diluted Average Shares | 86,759,812 |
| Assets | $187.00M |
| Current Assets | $186.02M |
| Prepaid Expenses | $449.00K |
| Other Current Assets | $185.57M |
| Noncurrent Assets | $983.00K |
| Fixed Assets | $116.00K |
| Other Non-current Assets | $867.00K |
| Liabilities | $3.67M |
| Current Liabilities | $3.27M |
| Wages | $541.00K |
| Other Current Liabilities | $2.73M |
| Noncurrent Liabilities | $394.00K |
| Equity | $183.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $183.33M |
| Liabilities And Equity | $187.00M |
| Net Cash Flow From Operating Activities | -$19.79M |
| Net Cash Flow From Operating Activities, Continuing | -$19.79M |
| Net Cash Flow From Investing Activities | -$26.00K |
| Net Cash Flow From Investing Activities, Continuing | -$26.00K |
| Net Cash Flow From Financing Activities | $101.48M |
| Net Cash Flow From Financing Activities, Continuing | $101.48M |
| Net Cash Flow | $81.66M |
| Net Cash Flow, Continuing | $81.66M |
| Comprehensive Income/Loss | -$41.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$41.78M |
| Other Comprehensive Income/Loss | -$41.78M |
| Other Comprehensive Income/Loss Attributable To Parent | -$236.00K |